CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 84 filers reported holding CRINETICS PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $823 | +100.7% | 27,681 | +21.7% | 0.00% | 0.0% |
| Q2 2023 | $410 | -11.3% | 22,739 | -20.9% | 0.00% | 0.0% |
| Q1 2023 | $462 | -35.5% | 28,764 | -26.5% | 0.00% | 0.0% |
| Q4 2022 | $716 | -99.9% | 39,120 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $769,000 | +21.3% | 39,148 | +15.2% | 0.00% | 0.0% |
| Q2 2022 | $634,000 | -8.1% | 33,992 | +8.2% | 0.00% | 0.0% |
| Q1 2022 | $690,000 | -7.8% | 31,421 | +19.4% | 0.00% | 0.0% |
| Q4 2021 | $748,000 | +34.8% | 26,317 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $555,000 | -6.6% | 26,387 | -16.3% | 0.00% | 0.0% |
| Q2 2021 | $594,000 | +56.7% | 31,522 | +27.1% | 0.00% | – |
| Q1 2021 | $379,000 | +8.3% | 24,800 | 0.0% | 0.00% | – |
| Q4 2020 | $350,000 | -10.0% | 24,800 | 0.0% | 0.00% | – |
| Q3 2020 | $389,000 | -10.4% | 24,800 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $434,000 | +132.1% | 24,800 | +95.3% | 0.00% | – |
| Q1 2020 | $187,000 | -41.4% | 12,700 | 0.0% | 0.00% | – |
| Q4 2019 | $319,000 | +67.0% | 12,700 | 0.0% | 0.00% | – |
| Q3 2019 | $191,000 | -39.9% | 12,700 | 0.0% | 0.00% | – |
| Q2 2019 | $318,000 | +241.9% | 12,700 | +209.8% | 0.00% | – |
| Q1 2019 | $93,000 | -24.4% | 4,100 | 0.0% | 0.00% | – |
| Q4 2018 | $123,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |